List of Navitor Pharmaceuticals patents

List of Navitor Pharmaceuticals patents

List of University of Nottingham patents

List of Sunfire patents

List of Skunklock patents

List of funding rounds for Deep Blue Medical Advances

List of funding rounds for Epigenomics AG

Patents where

Current Assignee

Name

is

Navitor Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11345654 Polymorphic compounds and uses thereof	Patent 11345654 was granted and assigned to Navitor Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	11345654	May 31, 2022
	‌ US Patent 10100066 Modulators of sestrin-GATOR2 interaction and uses thereof	Patent 10100066 was granted and assigned to Navitor Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10100066	October 16, 2018
	‌ US Patent 11325924 Modulators of Sestrin-GATOR2 interaction and uses thereof		Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	11325924	May 10, 2022
	‌ US Patent 10912750 Modulators of Sestrin-GATOR2 interaction and uses thereof	Patent 10912750 was granted and assigned to Navitor Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10912750	February 9, 2021
	‌ US Patent 10683308 Rapamycin analogs and uses thereof	Patent 10683308 was granted and assigned to Navitor Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10683308	June 16, 2020
	‌ US Patent 10414782 Modulators of sestrin-GATOR2 interaction and uses thereof	Patent 10414782 was granted and assigned to Navitor Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10414782	September 17, 2019
	‌ US Patent 10752644 Modulators of Sestrin-GATOR2 interaction and uses thereof		Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10752644	August 25, 2020
	‌ US Patent 10844013 Phenyl amino piperidine mTORC inhibitors and uses thereof		Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10844013	November 24, 2020
	‌ US Patent 10980784 Rapamycin analogs and uses thereof	Patent 10980784 was granted and assigned to Navitor Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10980784	April 20, 2021
	‌ US Patent 10414727 Phenyl amino piperidine mTORC inhibitors and uses thereof	Patent 10414727 was granted and assigned to Navitor Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	10414727	September 17, 2019
	‌ US Patent 11339144 Heteroaryl Rheb inhibitors and uses thereof	Patent 11339144 was granted and assigned to Navitor Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Navitor Pharmaceuticals	Navitor Pharmaceuticals		United States Patent and Trademark Office	11339144	May 24, 2022

11 results

0 selected

11 results

0 selected